Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Semaglutide the original ~14.9% average body-weight reduction at 52 weeks Targets GLP-1 (one pathway) Weekly injection Best for: first-timers, or anyone sensitive to side effects Tirzepatide the upgrade ~22.1% average body-weight reduction at 52 weeks Targets GLP-1 + GIP (two pathways) Weekly injection Best for: plateaued on semaglutide, or want stronger results Retatrutide the newest ~25.9% average body-weight reduction at 52 weeks Targets GLP-1 + GIP + glucagon (three pathways) Weekly injection Best for: want the newest science, comfortable with a compounded option Semaglutide: the original Semaglutide is a GLP-1 receptor agonist
Store in a dry place, below 25C, away from direct sunlight
Free iron content and HIF-1 fluorescence level were quantified using Fiji open-source software
J.SynnottN
A., Yang, F., Rosenstock, J
US$ 22.65
US$ 29.89
US$ 28.15
US$ 20.86
US$ 25.32
US$ 23.85
